Topic: bone regeneration

MIT scientists designed a material that allows osteoarthritis drugs to more deeply penetrate cartilage-generating tissues.

A newly found stem cell can differentiate into just bone cells without the unwanted lineages found in previous cultures.

Researchers have discovered a molecule that promotes the growth of blood vessels in bone, reversing weakening and helping fractures heal.

The FDA has expanded the clearance of NuVasive’s limb-lengthening system to include bone transport.

Amgen and UCB's romosozumab trounced a comparator drug in a trial in osteoporosis, but there's a big catch: The therapy seems to cause side effects that will delay and could scupper its chances of reaching the market.

A Cedars-Sinai-led team has developed a treatment for fractured bone using ultrasound, stem cells and gene therapy.

Johnson & Johnson has acquired 3D-printing technology from Tissue Regeneration Systems.

Ultragenyx needed a win for its lead drug burosumab after a midstage pipeline failure and delivered with a good set of phase 3 results.